IP Library Patent Application 17128843
Patent Application
App. No. 17/128,843

METHODS AND KITS FOR NUCLEIC ACID SAMPLE PREPARATION FOR SEQUENCING

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/128,843
Abstract

The present disclosure relates to methods and kits for DNA library construction, particularly for consistent and reproducible DNA sequencing.

Claims (35)

1 - 30 . (canceled)

31 . A method for nucleic acid library construction, the method comprising:

end repairing nucleic acid fragments in a first reaction mixture;

A-tailing the end-repaired nucleic acid fragments in a second reaction mixture; and

ligating nucleic acid adaptors to the A-tailed nucleic acid fragments in a third reaction mixture,

wherein one or more of the first reaction mixture, the second reaction mixture, and the third reaction mixture are rehydrated from a lyophilized form in a reaction volume comprising the nucleic acid fragments.

32 . The method of claim 31 , wherein at least the first reaction mixture is rehydrated from a lyophilized form.

33 . The method of claim 32 , wherein the lyophilized form is one or more lyophilized pellets, each lyophilized pellet having a diameter of from about 0.3 cm to about 1.0 cm.

34 . The method of claim 33 , wherein the lyophilized pellet is lyophilized from an approximately 15 μl to approximately 300 μl volume.

35 . The method of claim 31 , wherein the first reaction mixture comprises a polymerase and a polynucleotide kinase.

36 . The method of claim 35 , wherein the polymerase is a T4 DNA polymerase, and wherein the polynucleotide kinase is a T4 polynucleotide kinase.

37 . The method of claim 35 , wherein the first reaction mixture further comprises deoxynucleotide triphosphates, a source of magnesium, and a buffer.

38 . The method of claim 32 , wherein the nucleic acid fragments in the reaction volume are added to a single use reaction tube containing the lyophilized first reaction mixture.

39 . The method of claim 31 , wherein at least the second reaction mixture is rehydrated from a lyophilized form.

40 . The method of claim 39 , wherein the lyophilized form is one or more lyophilized pellets, each lyophilized pellet having a diameter of from about 0.3 cm to about 1.0 cm.

41 . The method of claim 40 , wherein the lyophilized pellet is lyophilized from an approximately 15 μl to approximately 300 μl volume.

42 . The method of claim 31 , wherein the second reaction mixture comprises a (3′→5′ exo-) polymerase.

43 . The method of claim 42 , wherein the (3′→′ exo-) polymerase is a Klenow exo-).

44 . The method of claim 42 , wherein the second reaction mixture further comprises a source of magnesium, a source of sodium, dATP, and a buffer.

45 . The method of claim 39 , wherein the end-repaired nucleic acid fragments in the reaction volume are added to a single use reaction tube containing the lyophilized second reaction mixture.

46 . The method of claim 31 , wherein at least the third reaction mixture is rehydrated from a lyophilized form.

47 . The method of claim 46 , wherein the lyophilized form is one or more lyophilized pellets, each lyophilized pellet having a diameter of from about 0.3 cm to about 1.0 cm.

48 . The method of claim 47 , wherein the lyophilized pellet is lyophilized from an approximately 15 μl to approximately 300 μl volume.

49 . The method of claim 31 , wherein the third reaction mixture comprises a nucleic acid ligase.

50 . The method of claim 49 , wherein the nucleic acid ligase is a T4 DNA ligase.

51 . The method of claim 49 , wherein the third reaction mixture further comprises a source of magnesium, ATP, and a buffer.

52 . The method of claim 46 , wherein the A-tailed nucleic acid fragments in the reaction volume are added to a single use reaction tube containing the lyophilized third reaction mixture.

53 . The method of claim 31 , wherein at least two of the first reaction mixture, the second reaction mixture, and the third reaction mixture are rehydrated from a lyophilized form.

54 . The method of claim 31 , wherein each of the first reaction mixture, the second reaction mixture, and the third reaction mixture is rehydrated from a lyophilized form.

55 . The method of claim 31 , wherein the nucleic acid fragments comprise DNA fragments.

56 . A method for nucleic acid library construction, the method comprising:

end repairing nucleic acid fragments in a first reaction mixture, wherein the first reaction mixture comprises a polymerase and a polynucleotide kinase;

A-tailing the end-repaired nucleic acid fragments in a second reaction mixture, wherein the second reaction mixture comprises a (3′→5′ exo-) polymerase; and

ligating nucleic acid adaptors to the A-tailed nucleic acid fragments in a third reaction mixture, wherein the third reaction mixture comprises a nucleic acid ligase,

wherein one or more of the first reaction mixture, the second reaction mixture, and the third reaction mixture are rehydrated from a lyophilized form in a reaction volume comprising the nucleic acid fragments.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2025
From: ARCHERDX, LLC
To: INVITAE CORPORATION
Reel/Frame 073239/0615 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2024
From: INVITAE CORPORATION
To: LABORATORY CORPORATION OF AMERICA HOLDINGS
Reel/Frame 068822/0025 →
SECURITY INTEREST Recorded Mar 7, 2023
From: ARCHERDX, LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 062908/0095 →
SECURITY INTEREST Recorded Mar 7, 2023
From: ARCHERDX, LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 062908/0442 →
CHANGE OF NAME Recorded Aug 17, 2021
From: ARCHERDX, INC.
To: ARCHERDX, LLC
Reel/Frame 057199/0258 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 055658 FRAME: 0087. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 26, 2021
From: ENZYMATICS, INC.
To: ARCHERDX, INC.
Reel/Frame 055743/0117 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2021
From: FINN, PATRICK; PATTON, GREG; LIU, HONGBO
To: ENZYMATICS, INC.
Reel/Frame 055645/0279 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2021
From: ENZYMATICS, INC.,
To: ARCHER DX, INC.
Reel/Frame 055658/0087 →